Blood test could revolutionize breast cancer treatment decisions

NCT ID NCT05662345

Ongoing Knowledge-focused Sponsor: Menarini Silicon Biosystems, INC Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tracks 65 people with metastatic breast cancer to see if a blood test that finds cancer cells (called circulating tumor cells) helps doctors choose the right treatment and check if it's working. Participants give blood samples and doctors answer surveys about how useful the test is. The goal is to learn whether this test improves care, not to test a new drug.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for METASTATIC BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast cancer breast carcinoma breast neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

METASTATIC BREAST CANCER

Contacts and locations

Locations

MCHS Eau Claire

Eau Claire, Wisconsin, 54703, United States
Mayo Clinic

Rochester, Minnesota, 55905, United States
Mayo Clinic Health System Albert Lea

Albert Lea, Minnesota, 56007, United States
Mayo Clinic Health System Mankato

Mankato, Minnesota, 56001, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.